Slate Medicines
Advancing next-generation therapeutics for migraine and other headache disorders
$130MSeries A
Role not disclosedFC
Foresite Capital
Activity from announced rounds
Activity in this selectionSeries A
Foresite Capital is a healthcare investment firm identified by Abcuro and in its own Thyme Care portfolio record.
Recorded funding activity
Abcuro develops immunotherapies targeting pathogenic cytotoxic T cells. Thyme Care combines oncology care teams with technology, while Khartis develops oral medicines for immune and chronic diseases. The company histories distinguish care delivery from experimental drug development.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $305M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionKorsana Biosciences
Develops therapies for neurodegenerative diseases.
$175MSeries A
Role not disclosed